Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryushi Tazawa

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
American Journal of Respiratory Cell and Molecular Biology|June 13, 2022
Metabolic and Epigenetic Regulation of SMAD7 by STC1 Ameliorates Lung FibrosisShinya Ohkouchi, Masahiko Kanehira, Daisuke Saigusa, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 2005
Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosisRyushi Tazawa, Emi Hamano, Toru Arai, et al.
Annals of the American Thoracic Society|April 20, 2017
Sequential Granulocyte-Macrophage Colony-Stimulating Factor Inhalation after Whole-Lung Lavage for Pulmonary Alveolar Proteinosis. A Report of Five Intractable CasesShinya Ohkouchi, Keiichi Akasaka, Toshio Ichiwata, et al.
Current Issues in Molecular Biology|July 2, 2021
Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese CohortHiroki Maruyama, Atsumi Taguchi, Mariko Mikame, et al.
ERJ Open Research|March 27, 2018
Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosisTaizou Hirano, Shinya Ohkouchi, Naoki Tode, et al.
Pharmacoepidemiology and Drug Safety|July 29, 2017
Risk factors for stomatitis in patients with lymphangioleiomyomatosis during treatment with sirolimus: A multicenter investigator-initiated prospective studyNobutaka Kitamura, Kuniaki Seyama, Yoshikazu Inoue, et al.
American Journal of Respiratory and Critical Care Medicine|January 19, 2008
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in JapanYoshikazu Inoue, Bruce C Trapnell, Ryushi Tazawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2012
Runx1 deficiency in CD4+ T cells causes fatal autoimmune inflammatory lung disease due to spontaneous hyperactivation of cellsWon Fen Wong, Kazuyoshi Kohu, Akira Nakamura, et al.
Chest|October 26, 2013
Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapyRyushi Tazawa, Yoshikazu Inoue, Toru Arai, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 16, 2014
A mathematical model to predict protein wash out kinetics during whole-lung lavage in autoimmune pulmonary alveolar proteinosisKeiichi Akasaka, Takahiro Tanaka, Takashi Maruyama, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
American Journal of Respiratory Cell and Molecular Biology|June 13, 2022
Metabolic and Epigenetic Regulation of SMAD7 by STC1 Ameliorates Lung FibrosisShinya Ohkouchi, Masahiko Kanehira, Daisuke Saigusa, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 2005
Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosisRyushi Tazawa, Emi Hamano, Toru Arai, et al.
Annals of the American Thoracic Society|April 20, 2017
Sequential Granulocyte-Macrophage Colony-Stimulating Factor Inhalation after Whole-Lung Lavage for Pulmonary Alveolar Proteinosis. A Report of Five Intractable CasesShinya Ohkouchi, Keiichi Akasaka, Toshio Ichiwata, et al.
Current Issues in Molecular Biology|July 2, 2021
Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese CohortHiroki Maruyama, Atsumi Taguchi, Mariko Mikame, et al.
ERJ Open Research|March 27, 2018
Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosisTaizou Hirano, Shinya Ohkouchi, Naoki Tode, et al.
Pharmacoepidemiology and Drug Safety|July 29, 2017
Risk factors for stomatitis in patients with lymphangioleiomyomatosis during treatment with sirolimus: A multicenter investigator-initiated prospective studyNobutaka Kitamura, Kuniaki Seyama, Yoshikazu Inoue, et al.
American Journal of Respiratory and Critical Care Medicine|January 19, 2008
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in JapanYoshikazu Inoue, Bruce C Trapnell, Ryushi Tazawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2012
Runx1 deficiency in CD4+ T cells causes fatal autoimmune inflammatory lung disease due to spontaneous hyperactivation of cellsWon Fen Wong, Kazuyoshi Kohu, Akira Nakamura, et al.
Chest|October 26, 2013
Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapyRyushi Tazawa, Yoshikazu Inoue, Toru Arai, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 16, 2014
A mathematical model to predict protein wash out kinetics during whole-lung lavage in autoimmune pulmonary alveolar proteinosisKeiichi Akasaka, Takahiro Tanaka, Takashi Maruyama, et al.
Pageof 6